Article
Serological and molecular analysis of HLA in Israeli primary sclerosing cholangitis patients.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics - 1 Oct 1992
Amar A, Brautbar C, Goldin E, Sherman L, Barmeir S, Shouval D, Hansen J A, Smith A G
Abstract excerpt
HLA class I and class II were investigated in 15 Israeli primary sclerosing cholangitis patients and compared to healthy controls. None of the well established serological specificities were found to be associated with the disease. HLA-DR52 is serologically defined, but its subtypes DR52a, DR52b, and DR52c cannot be precisely defined by serological means. Therefore, we have used HLA-DNA typing in order to assign...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
